Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Highmark Wholecare | Ophthalmics, Antibiotic-Steroid Combinations | New policy |
| Aug 2, 2026 | Highmark Wholecare | Ophthalmics, Antibiotics | New policy |
| Aug 2, 2026 | Highmark Wholecare | Ophthalmics, Allergic Conjunctivitis | New policy |
| Aug 2, 2026 | Highmark Wholecare | Onpattro,Tegsedi and Amvuttra | New policy |
| Aug 2, 2026 | Highmark Wholecare | Oncology, IV/Injectable | New policy |
| Aug 2, 2026 | Highmark Wholecare | Oncology Agents, Oral | New policy |
| Aug 2, 2026 | Highmark Wholecare | Oncology Agents, Breast Cancer | New policy |
| Aug 2, 2026 | Highmark Wholecare | Obesity Treatment Agents | New policy |
| Aug 2, 2026 | Highmark Wholecare | Nuedexta | New policy |
| Aug 2, 2026 | Highmark Wholecare | NSAIDS | New policy |
| Aug 2, 2026 | Highmark Wholecare | Non-Formulary Medical Necessity | New policy |
| Aug 2, 2026 | Highmark Wholecare | Neuropathic Pain Agents | New policy |
| Aug 2, 2026 | Highmark Wholecare | Natalizumab | New policy |
| Aug 2, 2026 | Highmark Wholecare | Myasthenia Gravis Medications | New policy |
| Aug 2, 2026 | Highmark Wholecare | Myalept | New policy |
| Aug 2, 2026 | Highmark Wholecare | Multiple Sclerosis Agents | New policy |
| Aug 2, 2026 | Highmark Wholecare | Monoclonal Antibodies (MABs)- Anti-IL, Anti-IgE, Anti-TSLP | New policy |
| Aug 2, 2026 | Highmark Wholecare | Migraine Prevention Agents | New policy |
| Aug 2, 2026 | Highmark Wholecare | Migraine Acute Treatment Agents | New policy |
| Aug 2, 2026 | Highmark Wholecare | Methotrexate | New policy |
| Aug 2, 2026 | Highmark Wholecare | Macular Degeneration Agents | New policy |
| Aug 2, 2026 | Highmark Wholecare | Macrolides | New policy |
| Aug 2, 2026 | Highmark Wholecare | Lyfgenia | New policy |
| Aug 2, 2026 | Highmark Wholecare | Luxturna | New policy |
| Aug 2, 2026 | Highmark Wholecare | Local Anesthetics, Topical | New policy |
| Aug 2, 2026 | Highmark Wholecare | Livmarli | New policy |
| Aug 2, 2026 | Highmark Wholecare | Lipotropics, Statins | New policy |
| Aug 2, 2026 | Highmark Wholecare | Lipotropics, Other | New policy |
| Aug 2, 2026 | Highmark Wholecare | Leukotriene Modifiers | New policy |
| Aug 2, 2026 | Highmark Wholecare | Lantidra | New policy |
| Aug 2, 2026 | Highmark Wholecare | Joenja | New policy |
| Aug 2, 2026 | Highmark Wholecare | Isturisa | New policy |
| Aug 2, 2026 | Highmark Wholecare | Iron, Parenteral | New policy |
| Aug 2, 2026 | Highmark Wholecare | Iron Chelating Agents | New policy |
| Aug 2, 2026 | Highmark Wholecare | Intranasal Rhinitis Agents | New policy |
| Aug 2, 2026 | Highmark Wholecare | Intra-Articular Hyaluronates | New policy |
| Aug 2, 2026 | Highmark Wholecare | Immunosuppressives, Oral | New policy |
| Aug 2, 2026 | Highmark Wholecare | Immunomodulators, Topical | New policy |
| Aug 2, 2026 | Highmark Wholecare | Immunomodulators, Dermatologics | New policy |
| Aug 2, 2026 | Highmark Wholecare | Immune Globulin Products | New policy |
| Aug 2, 2026 | Highmark Wholecare | Imcivree (setmelanotide) | New policy |
| Aug 2, 2026 | Highmark Wholecare | Hypoglycemics, TZDs | New policy |
| Aug 2, 2026 | Highmark Wholecare | Hypoglycemics, Sulfonylureas | New policy |
| Aug 2, 2026 | Highmark Wholecare | Hypoglycemics, SGLT2 Inhibitors | New policy |
| Aug 2, 2026 | Highmark Wholecare | Hypoglycemics, Metformins | New policy |
| Aug 2, 2026 | Highmark Wholecare | Hypoglycemics, Meglitinides | New policy |
| Aug 2, 2026 | Highmark Wholecare | Hypoglycemics, Insulin and Related Agent | New policy |
| Aug 2, 2026 | Highmark Wholecare | Hypoglycemics, DPP-4 Inhibitors | New policy |
| Aug 2, 2026 | Highmark Wholecare | Hypoglycemics, Alpha-Glucosidase Inhibitors | New policy |
| Aug 2, 2026 | Highmark Wholecare | Hypoglycemia Treatments | New policy |